Gilead Sciences, Inc Patent Portfolio Statistics

tip_user1

Gilead Sciences, Inc.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Gilead Sciences, Inc. look like?

	Assignee	Art Units
Total Applications:	1,532	1,196,736
Granted Patents:	872	533,916
Grant Index	66.97% ↑	63.42%
Abandoned/Rejected Applications:	430 (33.03%)	307,946 (36.58%)
In-Process Applications:	224	354,874
Average Grant Time:	2.42 Years ↓	2.82 Years
Average Office Actions:	1.36 ↓	1.75

Which Technology Area Gilead Sciences, Inc. is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
1624	Organic Chemistry	196
1625	Organic Chemistry	138
1626	Organic Chemistry	128
1623	Organic Chemistry	110
1628	Organic Chemistry	103

How many patents are Gilead Sciences, Inc. filing every year?

Year	Total Applications	Predicted
2022	0*	313
2021	24*	384
2020	77	314
2019	68	68
2018	87	–
2017	102	–
2016	90	–
2015	95	–
2014	101	–
2013	85	–

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Gilead Sciences, Inc. in USPTO?

Publication number: None
Application number: 17/627,000

Abstract:
–

Publication date: –
Applicant: Gilead Sciences, Inc.
Inventors: J John Leonard

Publication number: US20220177449A1
Application number: 17/530,300

Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Publication date: 2022-06-09
Applicant: Gilead Sciences, Inc.
Inventors: G James Taylor

How are Gilead Sciences, Inc.’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17/627,000	Long-Acting Formulations Of Tenofovir Alafenamide	Application Undergoing Preexam Processing	1629	–
17/530,300	Glp-1R Modulating Compounds	–	OPAP	Central, Docket